14 results
SC14D9C
EX-2.1
PNT
POINT Biopharma Global Inc.
3 Oct 23
Written communication relating to third party tender offer
7:37am
, emission, discharge, leaking, emptying, pumping, pouring, injection, deposit, dumping, disposal, dispersal, leaching, escaping, migration, or other
8-K
EX-2.1
PNT
POINT Biopharma Global Inc.
3 Oct 23
Tender and Support Agreement
7:35am
, emission, discharge, leaking, emptying, pumping, pouring, injection, deposit, dumping, disposal, dispersal, leaching, escaping, migration, or other
ARS
2022 FY
PNT
POINT Biopharma Global Inc.
1 May 23
Annual report to shareholders
1:52pm
and manufacturing with Lantheus’ commercial leadership in prostate-specific membrane antigen - positron emission tomography ("PSMA-PET") and radiopharmaceuticals … approved the first drug for positron emission tomography ("PET") imaging of PSMA-positive lesions in individuals with prostate cancer, 68Ga-PSMA-11. In May
8-K
EX-99.2
PNT
POINT Biopharma Global Inc.
12 Sep 22
POINT Biopharma Provides Updated Efficacy and Safety Data from the Lead-In Cohort of the Phase 3 SPLASH Trial in mCRPC at ESMO Congress 2022
7:54am
emission tomography–computed tomography; PR, partial response; PSA, prostate-specific antigen; PSMA, prostate-specific membrane antigen; pts, participants
424B3
PNT
POINT Biopharma Global Inc.
31 Mar 22
Prospectus supplement
11:42am
over-expresses PSMA. In December 2020 the FDA approved the first drug for positron emission tomography ("PET") imaging of PSMA positive lesions in men
POS AM
xq3w3s67jyceet3r7is
25 Mar 22
Prospectus update (post-effective amendment)
8:41am
424B3
EX-99.1
ow03 v9sctnm
25 Feb 22
Prospectus supplement
8:39am
8-K
EX-99.1
2dztji5w3
25 Feb 22
Regulation FD Disclosure
8:38am
8-K
EX-99.1
iwlr5o3tgu yjj9
19 Nov 21
Regulation FD Disclosure
8:09am
424B3
m8au yfbg
5 Aug 21
Prospectus supplement
4:26pm
S-4
EX-10.17
m6nq6q7pnimn
22 Mar 21
Registration of securities issued in business combination transactions
9:52pm
S-4
1c2 w2h6m
22 Mar 21
Registration of securities issued in business combination transactions
9:52pm
- Prev
- 1
- Next